JY
BFRIW icon

Jeff Yass’s Biofrontera BFRIW Stock Holding History

Jeff Yass’s Portfolio BFRIW Stock Details BFRIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-45,804
Closed -$1.83K – 13385
2026
Q1 		$1.83K Sell
45,804
-2,694
-6% -$144 ﹤0.01% 13021
2025
Q4 		$4.36K Buy
48,498
+2,611
+6% +$242 ﹤0.01% 12099
2025
Q3 		$4.78K Buy
45,887
+34,088
+289% +$4.28K ﹤0.01% 12134
2025
Q2 		$1.24K Buy
+11,799
New +$996 ﹤0.01% 12507
2024
Q2 		– Sell
-16,962
Closed -$1.15K – 12049
2024
Q1 		$1.15K Sell
16,962
-419
-2% -$12 ﹤0.01% 12009
2023
Q4 		$90 Buy
17,381
+5,526
+47% +$138 ﹤0.01% 12240
2023
Q3 		$462 Buy
+11,855
New +$1.07K ﹤0.01% 11901
2023
Q2 		– Sell
-13,485
Closed -$3.3K – 12067
2023
Q1 		$3.3K Sell
13,485
-7,622
-36% -$1.91K ﹤0.01% 12337
2022
Q4 		$4.24K Sell
21,107
-1,742
-8% -$704 ﹤0.01% 12066
2022
Q3 		$14K Sell
22,849
-3,303
-13% -$2.06K ﹤0.01% 12713
2022
Q2 		$18K Buy
+26,152
New +$28.8K ﹤0.01% 12387

Other funds holding BFRIW

BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's BFRIW Position: Q2 2026 in Review

Jeff Yass sold out of Biofrontera (BFRIW) in Q2 2026, closing a stake of 45,804 shares — an estimated $1.83K sold.

Jeff Yass first reported a position in BFRIW in Q2 2022 and held it in 11 quarters. The position peaked at $18K in Q2 2022. 5 funds tracked by Wall St. Rank hold BFRIW as of Q2 2026.

  • Jeff Yass reported no remaining Biofrontera position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 45,804 Biofrontera shares in Q2 2026, an estimated $1.83K.
  • Jeff Yass first reported a position in Biofrontera in Q2 2022 and held it in 11 quarters.
  • Jeff Yass's Biofrontera position peaked at $18K in Q2 2022.
  • 5 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.